LP
EVH icon

LMR Partners’s Evolent Health EVH Stock Holding History

LMR Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-68,137
Closed -$645K – 1465
2025
Q1 		$645K Hold
68,137
– – 0.01% 872
2024
Q4 		$767K Sell
68,137
-195,569
-74% -$3.44M 0.01% 768
2024
Q3 		$7.46M Buy
+263,706
New +$6.8M 0.06% 276
2017
Q2 		– Sell
-100,000
Closed -$2.23M – 627
2017
Q1 		$2.23M Buy
+100,000
New +$1.92M 0.21% 79

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LMR Partners's EVH Position: Q2 2025 in Review

LMR Partners sold out of Evolent Health (EVH) in Q2 2025, closing a stake of 68,137 shares — an estimated $645K sold.

LMR Partners first reported a position in EVH in Q1 2017 and held it in 4 quarters. The position peaked at $7.46M in Q3 2024. 220 funds tracked by Wall St. Rank hold EVH as of Q2 2025.

  • LMR Partners reported no remaining Evolent Health position as of Q2 2025 after selling out during the quarter.
  • LMR Partners sold 68,137 Evolent Health shares in Q2 2025, an estimated $645K.
  • LMR Partners first reported a position in Evolent Health in Q1 2017 and held it in 4 quarters.
  • LMR Partners's Evolent Health position peaked at $7.46M in Q3 2024.
  • 220 funds tracked by Wall St. Rank held Evolent Health as of Q2 2025.

Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.